These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29047342)

  • 41. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet aggregation inhibitors in primary and secondary prevention of ischemic stroke.
    Gorenoi V; Kulp W; Greiner W; von der Schulenburg JM
    GMS Health Technol Assess; 2006 Apr; 2():Doc09. PubMed ID: 21289960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing.
    Schlender L; Martinez YV; Adeniji C; Reeves D; Faller B; Sommerauer C; Al Qur'an T; Woodham A; Kunnamo I; Sönnichsen A; Renom-Guiteras A
    BMC Geriatr; 2017 Oct; 17(Suppl 1):227. PubMed ID: 29047344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Kahwati LC; Yun JDY; Middleton JC; Coker-Schwimmer M; Asher GN
    JAMA; 2018 Aug; 320(5):485-498. PubMed ID: 30088015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
    Aguilar M; Hart R
    Cochrane Database Syst Rev; 2005 Oct; (4):CD001925. PubMed ID: 16235290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
    Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
    BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Stroke prevention in atrial fibrillation.
    Voukalis C; Shantsila E; Lip GY
    J R Coll Physicians Edinb; 2017 Mar; 47(1):13-23. PubMed ID: 28569277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral Anticoagulant Use in Atrial Fibrillation-Associated Ischemic Stroke: A Retrospective, Multicenter Survey in Northwestern China.
    Zhang J; Yang XA; Zhang Y; Wei JY; Yang F; Gao H; Jiao WW; Sun XL; Gao Q; Jiang W
    J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):125-131. PubMed ID: 27645612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.
    Joundi RA; Cipriano LE; Sposato LA; Saposnik G;
    Stroke; 2016 May; 47(5):1364-7. PubMed ID: 27026630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database.
    Giner-Soriano M; Roso-Llorach A; Vedia Urgell C; Castells X; Capellà D; Ferreira-González I; Elorza-Ricart JM; Casajuana M; Troncoso Mariño A; Diògene E; Bolíbar B; Violan C; Morros R
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):97-107. PubMed ID: 27868275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secondary prevention of stroke in elderly people in Poland--results of PolSenior study.
    Labuz-Roszak B; Skrzypek M; Pierzchała K; Machowska-Majchrzak A; Mossakowska M; Chudek J; Mańka-Gaca I; Bartman W; Więcek A
    Neurol Neurochir Pol; 2014; 48(2):85-90. PubMed ID: 24821632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation.
    Quinn GR; Severdija ON; Chang Y; Singer DE
    Circulation; 2017 Jan; 135(3):208-219. PubMed ID: 27799272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.